Global Prosthetic Heart Valves Market is expected to register a CAGR of approx. 11% over the period of 2022-2028. The prosthetic heart valve market is rising due to the growing number of people suffering from heart valvular diseases. Some novel advancement in the making of the heart valve is increasing which is likely to aid the growth of the prosthetic heart valve market. For instance, in March 2021, the U.S. FDA approved the Harmony TPV (Transcatheter Pulmonary Valve) System for the treatment of adult and pediatric patients having a native or surgically repaired RVOT (right ventricular outflow tract). Owing to these glaring statistics the demand for prosthetic heart valves is anticipated to grow in the forthcoming years as their chances of recovery after surgery are very high and they are harmless. According to UnivDatos Market Insights (UMI)’ research report “global prosthetic heart valves market”, the market is expected to witness a robust growth during the forecast period 2022-2028F. Moreover, the availability of computational tools allows for accurate valvar disease detection, which leads to proper treatment fueling the demand for the prosthetic heart valve market. Furthermore, the growing demand for minimally invasive surgeries is expected to drive the market for prosthetic heart valve market in the coming years.
Unlock The Table of Content, And Request a
Sample Report - https://univdatos.com/get-a-free-sample-form-php/?product_id=28672
Based on the types of
valves, the prosthetic heart valve market is
segmented into transcatheter heart valves, tissue heart valves, and mechanical
heart valves. The transcatheter heart valve segment accounted for a significant
market share and it is estimated that it will grow rapidly during the projected
timeframe because of an increase in cardiovascular disease and a rise in demand
for cardiac valve replacement therapy.
Based on the end-users,
the market is bifurcated into hospitals, ambulatory surgical centers, and
others. The hospital segment accounted for a significant market share and it is
estimated that it will grow rapidly during the projected timeframe owing to the
increasing construction of hospitals and a surge in the number of heart
surgeries in the hospital setting.
North America to
witness extensive growth
For a better understanding of the market
adoption of the prosthetic heart valves market, the market is analyzed based on
its worldwide presence in the countries such as North America (United States,
Canada, and Rest of North America), Europe (Germany, France, Italy, Spain,
United Kingdom, and Rest of Europe), Asia-Pacific (China, Japan, India,
Australia, and Rest of APAC), and Rest of World. North America constitutes a
major market for the prosthetic heart valve industry owing to the rise in
medical expertise, new product launches, and government regulations that
provide favorable reimbursement scenarios.
For More Informative Information, Please Visit
Us – https://univdatos.com/report/prosthetic-heart-valves-market/
According to UnivDatos Market Insights (UMI)’,
the key players with a considerable market share in the global prosthetic heart
valves market are Edwards Lifesciences Corporation,
Medtronic plc., Boston Scientific Corporation, Abbott Laboratories, LivaNova
PLC, Artivion Inc, Braile Biomédica, Colibri Heart Valve LLC, JenaValve
Technology Inc, Micro Interventional Devices Inc Several M&A’s along with
partnerships have been undertaken by these players to boost their presence in
different regions.
“Global Prosthetic
Heart Valves Market” provides comprehensive qualitative and quantitative insights on
the industry potential, key factors impacting sales and purchase decisions,
hotspots, and opportunities available for the market players. Moreover, the
report also encompasses the key strategic imperatives for success for
competitors along with strategic factorial indexing measuring competitor's
capabilities on different parameters. This will help companies in the
formulation of go-to-market strategies and identifying the blue ocean for its
offerings.
Market Segmentations:
1.
By Types Of Valves (Transcatheter
Heart Valve, Tissue Heart Valve, Mechanical Heart Valve)
2.
By Diseases (Aortic Valve
Disease, Mitral Valve Disease, Pulmonary Valve Disease)
3.
By End-Users (Hospitals,
Ambulatory Surgical Centers, Others)
4.
By Region (North America,
Europe, Asia-Pacific, Rest of the World)
5.
By Company (Edwards
Lifesciences Corporation, Medtronic plc., Boston Scientific Corporation, Abbott
Laboratories, LivaNova PLC, Artivion Inc, Braile Biomédica, Colibri Heart Valve
LLC, JenaValve Technology Inc, Micro Interventional Devices Inc.)
Key
questions answered in the study:
1. What
are the current and future trends of the global prosthetic heart valve industry?
2. How
the industry has been evolving in terms of types of valves, diseases, and end-users?
3. How
the competition has been shaping across the countries followed by their
comparative factorial indexing?
4. What
are the key growth drivers and challenges for the global prosthetic heart valve
industry?
5.
What is the customer
orientation, purchase behavior, and expectations from the global prosthetic
heart valve suppliers across various region and countries?
Comments